Agentes terapéuticos para el tratamiento de enfermedades asociadas con proliferación celular no deseada
Un anticuerpo neutralizante anti-LIF para su uso en el tratamiento de glioma mediante la inhibición de la proliferación de células madre tumorales. The invention is based on observing that LIF is capable of activating the self-renewal of tumor stem cells in cancer, in particular gliomas, which indic...
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Format: | Patent |
| Sprache: | spa |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | PENUELAS PRIETO, Silvia BASELGA TORRES, José SEOANE SUAREZ, Joan |
| description | Un anticuerpo neutralizante anti-LIF para su uso en el tratamiento de glioma mediante la inhibición de la proliferación de células madre tumorales.
The invention is based on observing that LIF is capable of activating the self-renewal of tumor stem cells in cancer, in particular gliomas, which indicates that the inhibition of LIF, and generally of IL-6 type cytokines, can be used in therapeutic compositions for the treatment of diseases associated with unwanted proliferation. The invention also relates to a method for the identification of compounds capable of blocking/inhibiting the proliferation of stem cells, and to an in vitro method for the diagnosis of diseases associated with unwanted cell proliferation in a subject or for determining the predisposition of a subject to suffer said disease associated with unwanted cell proliferation, or for prognosis of average life expectancy of subjects suffering from said tumors. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_ES2864639TT3</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>ES2864639TT3</sourcerecordid><originalsourceid>FETCH-epo_espacenet_ES2864639TT33</originalsourceid><addsrcrecordid>eNqNy7ENwjAUhOE0FAjY4TEADUYRlBEKosd99GRfkCXHtvycoagZIYthJAaguuK-f9247olQIFSQOS2vuTgThRJnJngqmQtPrpJIFoQwIk-wbGvBEo1jy0ImBko5eldfNm55BzLws-dM4dsJKts2q5G9YPfbTbO_9fp6PyDFAZLYIKAM_eN4bk-tumit1D_mA1XIQvU</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Agentes terapéuticos para el tratamiento de enfermedades asociadas con proliferación celular no deseada</title><source>esp@cenet</source><creator>PENUELAS PRIETO, Silvia ; BASELGA TORRES, José ; SEOANE SUAREZ, Joan</creator><creatorcontrib>PENUELAS PRIETO, Silvia ; BASELGA TORRES, José ; SEOANE SUAREZ, Joan</creatorcontrib><description>Un anticuerpo neutralizante anti-LIF para su uso en el tratamiento de glioma mediante la inhibición de la proliferación de células madre tumorales.
The invention is based on observing that LIF is capable of activating the self-renewal of tumor stem cells in cancer, in particular gliomas, which indicates that the inhibition of LIF, and generally of IL-6 type cytokines, can be used in therapeutic compositions for the treatment of diseases associated with unwanted proliferation. The invention also relates to a method for the identification of compounds capable of blocking/inhibiting the proliferation of stem cells, and to an in vitro method for the diagnosis of diseases associated with unwanted cell proliferation in a subject or for determining the predisposition of a subject to suffer said disease associated with unwanted cell proliferation, or for prognosis of average life expectancy of subjects suffering from said tumors.</description><language>spa</language><subject>CHEMISTRY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2021</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20211014&DB=EPODOC&CC=ES&NR=2864639T3$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76290</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20211014&DB=EPODOC&CC=ES&NR=2864639T3$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>PENUELAS PRIETO, Silvia</creatorcontrib><creatorcontrib>BASELGA TORRES, José</creatorcontrib><creatorcontrib>SEOANE SUAREZ, Joan</creatorcontrib><title>Agentes terapéuticos para el tratamiento de enfermedades asociadas con proliferación celular no deseada</title><description>Un anticuerpo neutralizante anti-LIF para su uso en el tratamiento de glioma mediante la inhibición de la proliferación de células madre tumorales.
The invention is based on observing that LIF is capable of activating the self-renewal of tumor stem cells in cancer, in particular gliomas, which indicates that the inhibition of LIF, and generally of IL-6 type cytokines, can be used in therapeutic compositions for the treatment of diseases associated with unwanted proliferation. The invention also relates to a method for the identification of compounds capable of blocking/inhibiting the proliferation of stem cells, and to an in vitro method for the diagnosis of diseases associated with unwanted cell proliferation in a subject or for determining the predisposition of a subject to suffer said disease associated with unwanted cell proliferation, or for prognosis of average life expectancy of subjects suffering from said tumors.</description><subject>CHEMISTRY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2021</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNy7ENwjAUhOE0FAjY4TEADUYRlBEKosd99GRfkCXHtvycoagZIYthJAaguuK-f9247olQIFSQOS2vuTgThRJnJngqmQtPrpJIFoQwIk-wbGvBEo1jy0ImBko5eldfNm55BzLws-dM4dsJKts2q5G9YPfbTbO_9fp6PyDFAZLYIKAM_eN4bk-tumit1D_mA1XIQvU</recordid><startdate>20211014</startdate><enddate>20211014</enddate><creator>PENUELAS PRIETO, Silvia</creator><creator>BASELGA TORRES, José</creator><creator>SEOANE SUAREZ, Joan</creator><scope>EVB</scope></search><sort><creationdate>20211014</creationdate><title>Agentes terapéuticos para el tratamiento de enfermedades asociadas con proliferación celular no deseada</title><author>PENUELAS PRIETO, Silvia ; BASELGA TORRES, José ; SEOANE SUAREZ, Joan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_ES2864639TT33</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>spa</language><creationdate>2021</creationdate><topic>CHEMISTRY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>PENUELAS PRIETO, Silvia</creatorcontrib><creatorcontrib>BASELGA TORRES, José</creatorcontrib><creatorcontrib>SEOANE SUAREZ, Joan</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>PENUELAS PRIETO, Silvia</au><au>BASELGA TORRES, José</au><au>SEOANE SUAREZ, Joan</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Agentes terapéuticos para el tratamiento de enfermedades asociadas con proliferación celular no deseada</title><date>2021-10-14</date><risdate>2021</risdate><abstract>Un anticuerpo neutralizante anti-LIF para su uso en el tratamiento de glioma mediante la inhibición de la proliferación de células madre tumorales.
The invention is based on observing that LIF is capable of activating the self-renewal of tumor stem cells in cancer, in particular gliomas, which indicates that the inhibition of LIF, and generally of IL-6 type cytokines, can be used in therapeutic compositions for the treatment of diseases associated with unwanted proliferation. The invention also relates to a method for the identification of compounds capable of blocking/inhibiting the proliferation of stem cells, and to an in vitro method for the diagnosis of diseases associated with unwanted cell proliferation in a subject or for determining the predisposition of a subject to suffer said disease associated with unwanted cell proliferation, or for prognosis of average life expectancy of subjects suffering from said tumors.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | spa |
| recordid | cdi_epo_espacenet_ES2864639TT3 |
| source | esp@cenet |
| subjects | CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
| title | Agentes terapéuticos para el tratamiento de enfermedades asociadas con proliferación celular no deseada |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-03T20%3A19%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=PENUELAS%20PRIETO,%20Silvia&rft.date=2021-10-14&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EES2864639TT3%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |